Bruker
BRKR
359 hedge funds and large institutions have $8.73B invested in Bruker in 2023 Q2 according to their latest regulatory filings, with 76 funds opening new positions, 125 increasing their positions, 119 reducing their positions, and 34 closing their positions.
127% more call options, than puts
Call options by funds: $8.97M | Put options by funds: $3.95M
124% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 34
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
13% more funds holding
Funds holding: 319 → 359 (+40)
10.1% more ownership
Funds ownership: 70.55% → 80.65% (+10%)
7% more capital invested
Capital invested by funds: $8.16B → $8.73B (+$572M)
5% more repeat investments, than reductions
Existing positions increased: 125 | Existing positions reduced: 119
Top Buyers
| 1 |
PCA
Pallas Capital Advisors
Braintree,
Massachusetts
|
+$1.07B |
| 2 |
RI
RTW Investments
New York
|
+$135M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$101M |
| 4 |
CAM
Congress Asset Management
Boston,
Massachusetts
|
+$98.1M |
| 5 |
Goldman Sachs
New York
|
+$54.1M |
Top Sellers
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$80M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$57.3M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$48.6M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$47.3M |
| 5 |
Millennium Management
New York
|
-$44.1M |
BRKR Hedge Fund Activity: Q2 2023 in Review
359 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Bruker (BRKR) for Q2 2023, worth a combined $8.73B — up 7% from $8.16B a quarter earlier.
Buyers outnumbered sellers: 76 funds opened new BRKR positions and 34 closed out — a net gain of 42 holders — while 125 added to existing stakes and 119 trimmed.
The largest buyer was Pallas Capital Advisors, adding an estimated $1.07B. The largest seller was T. Rowe Price Investment Management, cutting an estimated $80M.
- 359 institutional investors held Bruker (BRKR) as of Q2 2023, up from 319 in Q1 2023.
- Funds reported $8.73B of Bruker stock for Q2 2023, up 7% quarter-over-quarter.
- 76 funds opened new Bruker positions in Q2 2023 and 34 closed out, a net change of +42 holders.
- The largest Bruker buyer in Q2 2023 was Pallas Capital Advisors, an estimated $1.07B added.
- The largest Bruker seller in Q2 2023 was T. Rowe Price Investment Management, an estimated $80M sold.
Based on aggregated 13F filings for Q2 2023.